Analystreport

Selecta Biosciences Inc (NASDAQ: SELB) had its "buy" rating re-affirmed by analysts at William Blair.

Selecta Biosciences, Inc.  (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report